Literature DB >> 2154362

Recovery of uremic neuropathy after renal transplantation.

R M Hupperts1, K M Leunissen, J P van Hooff, J Lodder.   

Abstract

Two patients are presented with progressive invalidating uremic peripheral neuropathy. The peripheral neuropathy developed despite frequent hemodialysis with a polyacrylonitrile membrane and afterwards in combination with CAPD. The first patient with a long history of progressive peripheral neuropathy before renal transplantation recovered incompletely after renal transplantation, whereas the second patient with a short history of a severe progressive UPN recovered completely after renal transplantation.

Entities:  

Mesh:

Year:  1990        PMID: 2154362     DOI: 10.1016/0303-8467(90)90014-v

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  4 in total

1.  Rapid reversal of uremic neuropathy following renal transplantation in an adolescent.

Authors:  Doreen T Ho; Nancy M Rodig; Heung B Kim; Hart G W Lidov; Frederic D Shapiro; G Praveen Raju; Peter B Kang
Journal:  Pediatr Transplant       Date:  2011-12-21

2.  The effect of a 9-month hybrid intradialytic exercise training program on nerve conduction velocity parameters in patients receiving hemodialysis therapy.

Authors:  Stefania S Grigoriou; Christina Karatzaferi; Christoforos D Giannaki; Gianna Patramani; Christina Vogiatzi; Georgia I Mitrou; Ioannis Stefanidis; Giorgos K Sakkas
Journal:  Int Urol Nephrol       Date:  2022-07-05       Impact factor: 2.370

3.  Cross-over, open-label trial of the effects of gabapentin versus pregabalin on painful peripheral neuropathy and health-related quality of life in haemodialysis patients.

Authors:  Huseyin Atalay; Yalcin Solak; Zeynep Biyik; Abduzhappar Gaipov; Figen Guney; Suleyman Turk
Journal:  Clin Drug Investig       Date:  2013-06       Impact factor: 2.859

4.  Impact of nocturnal hemodialysis on peripheral uremic neuropathy.

Authors:  Sassan Ghazan-Shahi; Timothy Jee Kam Koh; Christopher T Chan
Journal:  BMC Nephrol       Date:  2015-08-12       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.